Efficacy of liraglutide added to sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post‐hoc analysis of LIRA‐ADD2SGLT2i

AIMS: The LIRA‐ADD2SGLT2i trial demonstrated that liraglutide + sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) ± metformin significantly improved glycaemic control (not body weight) versus placebo in adults with type 2 diabetes (T2D). This post‐hoc analysis assessed whether baseline characteris...

Descripción completa

Detalles Bibliográficos
Autores principales: Blonde, Lawrence, Fainberg, Udi, Kaltoft, Margit S., Mosenzon, Ofri, Ramesh, Chethana, Rea, Rosangela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518913/
https://www.ncbi.nlm.nih.gov/pubmed/34132018
http://dx.doi.org/10.1111/dom.14464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518913/
https://www.ncbi.nlm.nih.gov/pubmed/34132018
http://dx.doi.org/10.1111/dom.14464

Ejemplares similares